Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita

Trial Profile

Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Palmoplantar keratoderma
  • Focus Pharmacokinetics
  • Sponsors TransDerm
  • Most Recent Events

    • 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jun 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top